GoHealth (GOCO)
(Delayed Data from NSDQ)
$10.15 USD
+0.14 (1.40%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $10.15 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
D Value B Growth A Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
GOCO 10.15 +0.14(1.40%)
Will GOCO be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for GOCO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GOCO
GoHealth (GOCO) Is Attractively Priced Despite Fast-paced Momentum
Is GoHealth (GOCO) a Great Value Stock Right Now?
GOCO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why You Should Hold on to Brighthouse Financial (BHF) Stock
Here's Why You Should Invest in Voya Financial (VOYA) Stock
Are Options Traders Betting on a Big Move in GoHealth (GOCO) Stock?
Other News for GOCO
GoHealth to Announce First Quarter 2024 Results on May 9, 2024
Upcoming Deadline to Share in GoHealth, Inc. (GOCO) Class Action Settlement
GoHealth to Present at Medicarians 2024: The Home of Senior Health, Wealth, and AgeTech
GoHealth to Present at the LD Micro Invitational XIV
Warning: GOCO is at high risk of performing badly